Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation by Malecka, Anna et al.
Article
Stromal fibroblasts support dendritic cells to
maintain IL-23/Th17 responses after
exposure to ionizing radiation
Anna Malecka,* Qunwei Wang,* Sabaria Shah,* Ruhcha V. Sutavani,†,‡ Ian Spendlove,†
Judith M. Ramage,† Julie Greensmith,*,§ Hester A. Franks,* Michael J. Gough,{ Anja Saalbach,‖
Poulam M. Patel,* and Andrew M. Jackson*,1
*Host-Tumour Interactions Group, †Cancer Immunotherapy Group, Division of Cancer and Stem Cells, and §Intelligent Modelling
and Analysis Research Group, University of Nottingham, Nottingham, United Kingdom; ‡Cell Signalling and Immunology,
University of Dundee, Scotland, United Kingdom; {Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence
Portland Medical Center, Portland, Oregon, USA; and ‖Klinik fur Dermatologie, University of Leipzig, Germany
RECEIVED OCTOBER 16, 2015; REVISED FEBRUARY 12, 2016; ACCEPTED MARCH 18, 2016. DOI: 10.1189/jlb.3A1015-474R
ABSTRACT
Dendritic cell function is modulated by stromal cells,
including fibroblasts. Although poorly understood, the
signals delivered through this crosstalk substantially
alter dendritic cell biology. This is well illustrated with
release of TNF-a/IL-1b from activated dendritic cells,
promoting PGE2 secretion from stromal fibroblasts. This
instructs dendritic cells to up-regulate IL-23, a key Th17-
polarizing cytokine. We previously showed that ionizing
radiation inhibited IL-23 production by human dendritic
cells in vitro. In the present study, we investigated the
hypothesis that dendritic cell-fibroblast crosstalk over-
comes the suppressive effect of ionizing radiation to
support appropriately polarized Th17 responses. Radia-
tion (1–6 Gy) markedly suppressed IL-23 secretion by
activated dendritic cells (P , 0.0001) without adversely
impacting their viability and consequently, inhibited the
generation of Th17 responses. Cytokine suppression by
ionizing radiation was selective, as there was no effect
on IL-1b, -6, -10, and -27 or TNF-a and only a modest
(11%) decrease in IL-12p70 secretion. Coculture with
fibroblasts augmented IL-23 secretion by irradiated
dendritic cells and increased Th17 responses. Impor-
tantly, in contrast to dendritic cells, irradiated fibroblasts
maintained their capacity to respond to TNF-a/IL-1b and
produce PGE2, thus providing the key intermediary
signals for successful dendritic cell-fibroblasts crosstalk.
In summary, stromal fibroblasts support Th17-polarizing
cytokine production by dendritic cells that would other-
wise be suppressed in an irradiated microenvironment.
This has potential ramifications for understanding the
immune response to local radiotherapy. These findings
underscore the need to account for the impact of
microenvironmental factors, including stromal cells, in
understanding the control of immunity. J. Leukoc. Biol.
100: 381–389; 2016.
Introduction
Crosstalk between DCs and stromal FBs has a marked impact on
DC function with regards to their ability to mature, migrate, and
trigger appropriate adaptive responses [1–3]. Whereas the impor-
tance of crosstalk between FBs and the immune system for the onset
and maintenance of cancer and autoimmunity was recently
recognized, the exact mechanisms governing these interactions and
the extent to which stromal cells affect the outcome of therapeutic
interventions, such as RT, remain poorly understood [4–7].
FBs play important roles in the pathology of a wide range of
diseases. Tumor-associated FBs promote tolerogenic DCs in
hepatic, breast, and ovarian cancers, whereas in pancreatic
cancer, they skew DCs to promote Th2 responses [8–11].
Pulmonary FBs are involved in the pathology of chronic
obstructive pulmonary disease and asthma by secreting CCL2
and CCL20 to attract DCs to airways and thus, maintain
chronic inﬂammation [12]. Likewise, synovial FBs are impli-
cated in the perpetuation of rheumatoid arthritis through
recruitment and activation of leukocytes, including T cells,
macrophages, and DCs [7, 13]. Recently, we established that
FBs modulate IL-23 secretion by DCs to promote Th17
responses, and this process was implicated in the maintenance
and progression of psoriatic lesions [3]. This model proposes
that dermal FBs respond to TNF-a and IL-1b, secreted from
activated DCs, by producing PGE2. FB-derived PGE2 acts in a
juxtacrine manner to amplify IL-23 release from DCs, thus
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supporting the generation of Th17 responses. The IL-23/Th17
axis is important for the development and maintenance of
autoimmune disorders, including rheumatoid arthritis, psori-
asis, and colitis [14–17]. IL-23 promotes tumor growth directly
and indirectly through Th17 responses that drive proliferation,
invasion, metastasis, and angiogenesis [18–23]. Furthermore,
it is implicated in the development of idiopathic and radiation-
induced ﬁbrosis [24, 25].
RT is a major tool for the treatment and palliation of tumors,
including squamous cell carcinoma of the skin, breast, and
primary brain tumors and brain metastases [26–28]. Current
protocols use fractionated RT, typically comprising relatively low
doses (1–6 Gy) of IR administered over a period of weeks [26, 29]
This allows tumor cells to be targeted with sufﬁcient cumulative
dose to deliver therapeutic beneﬁt, while restricting side-effects to
a tolerable minimum. However, during RT, immune and stromal
cells residing in and adjacent to the tumor niche are also affected
by IR through direct and bystander effects. Irradiated tumor cells
up-regulate MHC class I expression and secrete chemokines and
cytokines, such as CXCL16, TNF-a, IL-1b, and IL-6, which in turn,
stimulate inﬁltration and activation of DCs [30]. DCs are relatively
resistant to radiation-induced apoptosis, maintaining viability at
doses up to 30 Gy [31]. Their radio-resistance is a result of
constitutively expressed DNA repair systems, including ATM
kinase and DNA-dependent protein kinase [32]. However, despite
this, direct exposure of DCs to IR suppresses their function.
Irradiation of DCs down-regulates the production of the T cell-
polarizing cytokine IL-12 without affecting IL-10, thus changing
the ratio between pro- and anti-inﬂammatory stimuli and shifting
the balance from T cell activation to tolerance [31]. Furthermore,
we recently described that IR inhibits secretion of IL-23, another
T cell-polarizing cytokine, by DCs [33]. Taken together, this
suggests that in the setting of local RT, the cytokine “signal 3” from
activated DCs is substantially modiﬁed, thus altering the nature of
subsequent T cell responses.
Therefore, we investigated the hypothesis that local FBs
support IL-23 release by irradiated DCs and thereby, maintain
their ability to generate Th17 responses. Doses of radiation
consistent with those used for fractionated RT selectively
inhibited IL-23 and to a lesser extent, IL-12 by DCs, without
affecting IL-10, IL-6, IL-27, TNF-a, or IL-1b secretion. Interest-
ingly, IR did not affect the capacity of FBs to amplify IL-23
secretion by DCs. The coculture of irradiated FBs with irradiated
DCs up-regulated IL-23 secretion and increased Th17 responses.
We examined the factors by which FBs support the function of
DCs, despite the presence of IR, by using a DC-FB coculture
system in the presence of IR. The enhancing effect of FB was
mimicked by addition of PGE2 or forskolin to irradiated DCs and
was abrogated by treating FBs with the COX2 inhibitor
indomethacin. This effect occurred despite activation of the
ATM pathway in irradiated DCs, which we previously established
was involved in IL-23 down-regulation [33]. These ﬁndings
indicate that even after exposure to IR, activated FBs act through
secretion of PGE2 to activate the cAMP pathway in irradiated
DCs, leading to increased IL-23 secretion, independent of ATM
kinase. Our ﬁndings not only establish the signiﬁcance of FBs in
regulating DC responses but also highlight the complex interplay
between DCs and their microenvironment and illustrate the
importance of developing more comprehensive cell biology
models for understanding immunity.
MATERIALS AND METHODS
Reagents
All reagents were endotoxin free. rhGM-CSF and rhTNF-a were from
PeproTech (Rocky Hill, NJ, USA); IL-4 and IFN-g were from R&D Systems
Europe (Oxford, United Kingdom); Ultrapure TLR4 agonist (Salmonella
Minnesota LPS) was from InvivoGen (San Diego, CA, USA); rhIL-1b and rhIL-6
were from ImmunoTools (Friesoythe, Germany); IL-23 was from eBioscience
(San Diego, CA, USA); and PGE2, indomethacin, and forskolin were from
Sigma-Aldrich (Dorset, United Kingdom). Mouse anti-human CD4-PE was
from BD Biosciences (Oxford, United Kingdom); mouse anti-human CD4-PE-
Cy7, mouse anti-human CD45RA-FITC, mouse anti-human CD14-PE-Cy5.5,
and matching isotype controls were from eBioscience. For CD4 activation,
mouse anti-human CD28 was obtained from BD Biosciences, IL-2 from R&D
Systems Europe, and CD3 (OKT3) was produced in-house. The annexin V/PI
staining kit was obtained from BD Biosciences.
Generation of MoDCs
Mo-DCs were generated as described previously [34]. In brief, fresh blood
samples were obtained from healthy volunteers, and buffy coats were obtained
from the National Blood Transfusion Service, in accordance with the approval
of the relevant Ethical Review Boards. PBMCs were isolated using endotoxin-
free Histopaque 1.077 (Sigma-Aldrich) gradient centrifugation. CD14+
monocytes were puriﬁed using anti-CD14 magnetic beads (Miltenyi Biotec,
Bergisch Gladbach, Germany). DCs were generated by culture in DC medium
[RPMI 1640, 10% FCS, 1% sodium pyruvate (all from Sigma-Aldrich),
containing rhGM-CSF (1000 U/ml) and rhIL-4 (1000 U/ml)] for 5 d.
Additional complete medium was added on d 3. The purity and quality of DCs
were determined by ﬂow cytometry and morphologic analysis.
DC-FB coculture
The human dermal FB cell line BJ6 was obtained from Dr. Lloyd Hamilton
(University of Nottingham, United Kingdom), whereas primary dermal FBs
were obtained from Dr. Anja Saalbach (University of Leipzig, Germany). All
cells were tested free of mycoplasma infection before use. For coculture, FBs
were seeded in ﬂat-bottomed, 96-well plates and rested overnight. DCs were
added to FBs at a 4:1 ratio. Cocultures were incubated for 24 h in a humidiﬁed
atmosphere of 5% CO2 in air at 37°C. Supernatants were collected and stored
at 220°C. All experimental conditions were performed in biologic triplicates
and on multiple donors. In some experiments, the COX2 inhibitor
indomethacin (2 mM) was added to FB before coculture to determine the
contribution of PGE2 synthesis in the induction of IL-23. For assessment of
cell-cell interaction, a Transwell-permeable support system (Corning Life
Sciences, Tewksbury MA, USA) was used with FB in the lower and DC in the
upper chamber, separated by 3 mm pores. Primary FBs were used up until and
including the 4th passage, after which they were discarded.
Irradiation of cells
Cells were irradiated in tissue-culture plates immediately before DC
activation with LPS (500 ng/ml) and IFN-g (1000 U/ml). For experiments
with indomethacin, DCs were activated 3 h before irradiation and adding
to FBs to minimize the effect of COX2 inhibitor on DC maturation. Cells
were irradiated (0–6 Gy of 195 kVp X-rays, 0.87 Gy/min, 0.5 mm copper
ﬁlter, 48.4 cm focus to skin distance) using a cabinet irradiation system
(Gulmay; Xstrahl, Surrey, United Kingdom). Cell morphology was moni-
tored by phase-contrast microscopy (340) following IR and again after a
further 24 h of culture. Cell viability, apoptosis, and necrosis were
determined 24 h after radiation by blue exclusion and annexin V/PI FACS
using DMSO as a positive control (not shown). Flow cytometry was
performed using an FC500 ﬂow cytometer (Beckmann Coulter, Brea, CA,
USA) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
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Measurement of secreted cytokine
The secretion of IL-23p40/p19 or IL-12p70 was determined by commercial
human IL-23 Ready-SET-Go! ELISA (eBioscience) and human IL-12p70
ELISA kits (BD Biosciences). Assays did not signiﬁcantly react with other
proteins, and the sensitivities were 15 and 7.8 pg/ml, respectively. IL-6 was
measured by ELISA (ImmunoTools) with a sensitivity of 9 pg/ml. IL-1b,
TNF-a, IL-17, IL-27, and PGE2 were measured with DuoSet assays (R&D
Systems Europe), and assay sensitivity was 3.9, 15.6, 7.8, 156, and
30.9 pg/ml, respectively. Absorbance was measured at 450 nM using a
spectrophotometer.
Generation of Th17 responses
DC-FB cocultures were treated as described previously for 12 h and then
washed with fresh medium to limit the impact of LPS/IFN-g on T cells. We
previously established that IL-23 is not produced by DCs until .12 h after
TLR stimulation [35]. Human naı¨ve CD4+ T cells were obtained from
fractionated fresh whole blood, and naı¨ve CD4+ cells were obtained via a
2-step isolation procedure using the Naı¨ve CD4+ T cell isolation kit (Miltenyi
Biotec). Isolated T cells (CD4+CD45RA+, purity .95%) were cultured in
48-well plates at 2 3 105 cells/well. Allogeneic T cells were cultured in a 1:1
ratio of fresh medium and DC:FB coculture supernatant for 5 d in the
presence of anti-CD3 (OKT3; 1 mg/ml) and anti-CD28 (5 mg/ml) antibodies
with IL-2 (50 IU/ml). As controls for Th17 polarization and the importance
of IL-23, T cells were treated with rIL-1b, rIL-6, and rIL-23. T Cells were
rested for 2 d and restimulated with anti-CD3/anti-CD28. For ﬂow
cytometric assessment of Th17, cells were treated with Brefeldin A (BD
Biosciences) for 20 h, ﬁxed with 0.5% formaldehyde, permeabilized (Perm
Buffer; BioLegend, San Diego, CA, USA), and incubated with mouse anti-
human IL-17 FITC (eBioscience). Flow cytometry was performed using
Beckman Coulter FC500 ﬂow cytometer and analyzed with FlowJo software
(Tree Star). Supernatants from parallel cultures without Brefeldin A were
harvested after 48 h for ELISA.
Measurement of intracellular pATM
For measurement of intracellular pATM, cocultures were separated using
0.3 mm membrane Transwell plates (Corning Life Sciences). FBs were seeded
in the lower chamber and allowed to rest overnight before DCs were added to
the upper chambers. Cultures were irradiated and activated immediately with
LPS/IFN-g. After 12 h, DCs were ﬁxed in cold 2% formaldehyde/PBS and
permeabilized with cold methanol. The binding of primary pATM (Ser1981;
eBioscience) antibody was detected with a FITC-conjugated secondary
antibody (Dako, Glostrup, Denmark). Cells were acquired using a MACS-
Quant cytometer (Miltenyi Biotec) and analyzed using FlowJo (Tree Star).
Quantitation of mRNA level for IL-23A and IL-12B with
real-time RT-PCR
Real-time PCR was performed as described previously [33, 34]. In short,
cells were plated in DC medium, rested for 1 h, irradiated, and stimulated
immediately with LPS/IFN-g. RNA was isolated (NucleoSpin RNA II kit;
Macherey-Nagel, Du¨ren, Germany) and cDNA prepared using the GoScript
Reverse Transcription System (Promega, Madison, WI, USA). TaqMan
quantitative PCR was carried out for IL-12B and IL-23A with TOP1 as a
housekeeping gene (Thermo Fisher Scientiﬁc, Waltham, MA, USA; TOP1
Hs00243257_m1, Hs00168405_m1, IL-12B/IL-12p40 Hs00233688_m1,
IL-23A/IL-23p19 Hs00372324_m1) with MasterMix (Primerdesign, South-
ampton, United Kingdom) on a Mx3005P (Stratagene, La Jolla, CA, USA)
and analyzed with Stratagene software. Quantiﬁcation was done by the
DDCT method, where DCT = (gene of interest CT) 2 (TOP1 CT); DDCT
calculated with mDC at 0 Gy as a reference condition.
Statistical analysis
Results were statistically analyzed using Student’s t test or 2-way ANOVA in
GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Signiﬁcance levels
are indicated in the ﬁgure legends.
RESULTS
Irradiated FBs recover IL-23 secretion from
irradiated DCs
The impact of stromal cells on the response of DCs to IR has not
been studied previously. Therefore, we tested the hypothesis
that DC-FB crosstalk overcomes the immune-inhibitory effect of
IR. We recently established that exposure of DCs to IR inhibits
TLR4-dependent IL-23 secretion through the activation of ATM
kinase [33]. In agreement with this, irradiation of DCs
signiﬁcantly suppressed TLR-dependent IL-23 secretion.
Radiation-induced suppression of IL-23 was dose dependent
and maximal at 6 Gy (P , 0.001; Fig. 1A) and occurred in all
donors tested (P , 0.05; Fig. 1B and C and Table 1).
Coculture of FBs with TLR4-activated DCs (mDCs) markedly
increased the secretion of IL-23 (P , 0.05; Fig. 1D).
Furthermore, we determined the ability of irradiated FBs to
sustain IL-23 responses from irradiated DCs. It is noteworthy
that irradiated FBs maintained their ability to support increased
IL-23 secretion from irradiated DCs (P , 0.01) in all donors
(Fig. 1D). The levels of IL-23 secreted by irradiated mDCs
cocultured with irradiated FBs were greater than or equal to
those obtained from nonirradiated mDC controls. It should be
noted that whereas IL-23 secretion was increased in the
presence of FBs, the levels were nevertheless lower than those
obtained from nonirradiated cocultures. However, the fold
increase of IL-23 secretion by cocultures was similar regardless of
irradiation (Fig. 1E). The ability of FBs to increase IL-23
secretion by irradiated DCs was maintained regardless of whether
the BJ6 cell line or primary dermal FBs were used (Fig. 1F). As
expected, neither iDCs nor FBs secreted IL-23, irrespective of
irradiation status or addition of FBs (data not shown).
In the presence of IL-6 and IL-1b, IL-23 serves a key role in the
polarization of human naı¨ve CD4+ T cells toward a Th17
phenotype [33, 36]. Therefore, we determined whether the
protective effect conferred by FBs on IL-23 production resulted
in the induction of Th17 responses. Stimulation of naı¨ve CD4+
T cells through CD3/CD28 in the presence of conditioned
supernatants from mDC cultures elicited Th17 responses, as
shown by secretion of IL-17A (Fig. 1G). Furthermore, the
addition of FB to DC enhanced IL-17 secretion by T cells in all
donors tested, irrespective of exposure to IR.
Irradiated DCs maintain their ability to stimulate FBs
To determine the mechanism by which FBs increase IL-23
secretion in irradiated DCs, we tested each step in the DC-FB
coculture. Initially, we determined whether the secretion of
TNF-a and IL-1b were reduced by IR [2]. In contrast to IL-23,
DCs maintained their secretion of TNF-a and IL-1b following
exposure to IR (Table 1).
In view of the differential effect of IR on cytokine expression,
we assessed the secretion of other cytokines, including IL-12, IL-
27, IL-6, and IL-10 (Table 1). The inhibitory effect of IR was
restricted to IL-12 and IL-23, which share a common p40 subunit.
IR strongly down-regulated IL-23 and only suppressed IL-12 to a
modest extent. Interestingly, another member of the IL-12
family, IL-27, was unaffected. Production of the proinﬂammatory
cytokine IL-6, as well as anti-inﬂammatory IL-10, was unaffected
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by IR. Next, we determined whether IR affected transcription of
the IL-23-speciﬁc IL-23A gene or the common IL-12B gene that
encodes the p40 chain. Irradiation of DCs (6 Gy) signiﬁcantly
suppressed transcription of IL-23A compared with nonirradi-
ated DCs (P , 0.0001). Although the effect of IR on IL-12B was
also inhibitory, it was nevertheless less marked than on IL-23A
(Fig. 2A and B).
In contrast to many other cell types (e.g., monocytes), DCs
remain viable when irradiated [37]. This is because DCs (but not
classic monocytes) have constitutively active DNA repair systems
that repair double-strand DNA breaks [38]. Therefore, we
conﬁrmed that the suppression of IL-23 that we observed in
irradiated DCs was not a result of apoptosis or necrosis. IR did
not impact the viability of DCs. Staining with annexin V/PI
showed the viability of DCs to be to be unaffected by IR (Fig. 2C).
FBs are functionally unimpaired by IR
As irradiated DCs retained their ability to secrete TNF-a/IL-1b,
we next investigated the effect of IR on the response of FBs to
these cytokines. Coculture of irradiated FBs with nonirradiated
DCs did not impair their capacity to promote IL-23 release
from mDCs (Fig. 3A and B). Furthermore, irradiated FBs
retained their ability to respond to signals received from DCs
and secrete PGE2, as stimulation of irradiated BJ6 and primary
FBs with exogenous TNF-a/IL-1b elicited PGE2 secretion,
which was unaffected by radiation (Fig. 3C and D). As expected,
exposure of resting FBs to radiation did not elicit cytokine release.
In the absence of DCs, FBs did not secrete IL-6, IL-12, IL-10, IL-17,
IL-23, or IL-27 in response to activation with TNF-a, IL-1b, or
LPS/IFN-g, irrespective of exposure to IR (data not shown).
Irradiation had no impact on FB viability, as assessed by dye
exclusion (data not shown) and annexin V/PI staining (Fig. 3E). It
is important to stress that we examined the effects of IR on FBs
within the ﬁrst 24 h of exposure, after which time, activated DCs
would be expected to migrate to regional LNs [39].
FBs support function of irradiated DCs through
COX2-dependent PGE2 release
We previously established the importance of FBs for IL-23
secretion by DCs and demonstrated that this was mediated
through COX2-dependent PGE2 [3]. To assess whether this
mechanism was involved in irradiated cells, we ﬁrst demonstrated
TABLE 1. Effect of IR on cytokine secretion by mDCs
Cytokine % Remaining secretion sD P
IL-23 43 11 ,0.0001
IL-12 89 16.3 0.0005
IL-27 100.9 36.6 ns
IL-1b 93.5 34.4 ns
TNF-a 111.8 29.6 ns
IL-6 174.1 114.4 ns
IL-10 95.9 6.2 ns
DCs were irradiated (6 Gy) or nonirradiated before activation with
LPS/IFN-g. Supernatants were collected following 24 h incubation, and
secreted IL-23, IL-12, IL-27, IL-1b, TNF-a, IL-6, and IL-10 were measured
by ELISA. All experiments were repeated at least 4 times in triplicate, and
signiﬁcance was assessed with 2-way ANOVA.
Figure 1. FBs promote the IL-23–Th17 axis during irradiation. IR suppresses IL-23. DCs were irradiated before addition of LPS/IFN-g and IL-23
release measured by ELISA. (A) IL-23 suppression was dependent on the dose of IR (a representative donor from 3). (B) A representative experiment at
6 Gy. (C) A summary of 18 donors. (D) FBs rescue IL-23 secretion by irradiated DCs. Coculture of irradiated FBs with irradiated DCs up-regulated IL-23
secretion (summary of 8 donors). (E) Fold change of IL-23 secretion by irradiated DC/FB cocultures at 0 and 6 Gy. (F) Primary dermal FBs demonstrate
similar IL-23-enhancing activity to the BJ6 cell line (data from a representative donor or 5). (G) FBs permit irradiated DCs to promote Th17 responses.
IL-17A secretion by naı¨ve CD4+ T cells activated with anti-CD3/anti-CD28 in the presence of supernatants of the indicated DC/FB cultures. T cells were
stimulated for 5 d and IL-17A secretion determined after restimulation (collective data from 3 donors). Error bars indicate SD of triplicate experiments.
**0.01 . P $ 0.001, ***0.001 . P $ 0.0001, ****P , 0.0001; ns, not signiﬁcant. Results are presented as means 6 SD.
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the involvement of FB-derived soluble factors. FBs were separated
from DCs by a 0.3-mm porous membranes in Transwell plates.
Despite the lack of cell–cell contact, FBs retained their capacity
to support IL-23 secretion from irradiated DCs (Fig. 4A).
Therefore, we evaluated the involvement of PGE2 in up-
regulation of IL-23 secretion by irradiated DCs. The addition of
PGE2 to DCs immediately after irradiation and activation
resulted in a signiﬁcant increase of IL-23 secretion in all donors
tested (Fig. 4B). As PGE2 secretion by FB is usually COX2
dependent [2, 37], we determined the importance of COX2
activation for FB-dependent recovery of IL-23 secretion using
the COX2 inhibitor, indomethacin. IL-23 production from
irradiated cocultures was reduced signiﬁcantly by indomethacin
(Fig. 4C). In the presence of indomethacin, IL-23 secretion
from DC–FB cocultures was reduced to levels similar to those
achieved in the absence of FB.
FBs promote irradiated DC IL-23 responses through the
cAMP pathway
Irradiation of human DC monocultures selectively inhibits IL-23
by pATM kinase [33]. However, PGE2 also up-regulates IL-23
through activation of the cAMP–PKA signaling pathway [40,
41]. Interestingly, in lung cancer, cAMP signaling inhibits IR-
induced pATM [42]. Therefore, we sought to dissect the
molecular mechanism responsible for IL-23 secretion in
irradiated DC-FB cocultures.
Initially, we assessed ATM activation [3] in irradiated DC
monocultures or DC-FB cocultures. DC-FB cocultures were
separated by 0.3 mm porous membrane to ensure that pATM
levels were measured only in DCs. As expected, irradiation of
mDCs resulted in pATM after 2 h, and this persisted for at least
12 h, as demonstrated by intracellular staining with ﬂow
cytometry (Fig. 4D). However, coculture with FBs did not
suppress the levels of ATMs expressed by irradiated DCs,
suggesting that the support of DC function by FBs occurred
independently of ATM kinase. Lastly, we examined the in-
volvement of the cAMP pathway in regulation of IL-23 from
irradiated DCs. The addition of the cAMP active analog
forskolin to irradiated monocultures of mDCs resulted in a
Figure 2. Effect of IR on DCs. Changes in IL-23 secretion were
associated with decreased transcription of the (A) IL-23A gene and (B)
IL-12B gene, as shown using quantitative RT-PCR in 3 donors. Statistical
signiﬁcance was measured by the Student’s t test. (C) Despite exposure
to up to 6 Gy IR, there was no decrease in viability of DCs as assayed by
annexin V/PI staining with ﬂow cytometry up to 72 h after irradiation.
Representative result for 1 of 3 donors tested. ****P , 0.0001. Results
are presented as means 6 SD.
Figure 3. FBs are functionally resistant to IR. Irradiation of FBs did
not impair their ability to up-regulate IL-23 secretion from non-
irradiated DC. (A) A representative donor. (B) Summary of 3 donors.
(C) PGE2 secretion (determined by ELISA) by FBs stimulated with
rTNF-a and rIL-1b (1 ng/ml) is unaffected by IR; BJ6 cell line. (D)
Representative results for 1 of 2 primary FB donors. (E) IR (6 Gy)
does not affect FB viability up to 24 h after irradiation, as assessed by
annexin V/PI staining; representative data from 3 experiments.
***0.001 . P $ 0.0001. Results are presented as means 6 SD.
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dose-dependent increase in IL-23 (P , 0.01; Fig. 4E),
implicating a role for the cAMP signal transduction pathway.
DISCUSSION
Studies on the impact of the stromal microenvironment on
immunity are important as immune cells are in constant crosstalk
with their stroma during each and every stage of the immune
response. Stromal cells have the ability to affect a wide range of
immune functions, including DC maturation, their migration to
LNs, and subsequent polarization of T cell responses [1, 2, 12,
43]. The present study investigated the ability of stroma to
modulate the outcome of therapeutic interventions directed
toward the immune system. Our previous work established that
IR inhibits the cytokine response of DCs and in particular, IL-23
[33]. On the other hand, stromal FBs support IL-23 production
by activated DCs [2]. Therefore, we addressed the hypothesis that
FBs, cells that are known to be relatively radio resistant [44],
continue to support the function of DCs in the presence of IR.
The doses of IR used in the current study are similar to those
used during routine RT of common malignancies [26, 29]. At
these doses, IR damages transformed cells and initiated their
demise by generating free radicals that induce stress responses
and consequently, cell death if the damage is not repaired [29,
38, 45, 46]. As a result of their high proliferative rates and
impaired DNA repair mechanisms, many tumor types are
selectively sensitive to radiation-induced DNA damage [30, 47].
However, whereas tumor cells are the main target for RT,
immune and stromal cells residing in the tumor microenviron-
ment are also exposed to and affected by IR [48]. In this regard,
previous work using monocultures has shown that IR suppresses
IL-12 secretion by MoDCs between 2 and 20 Gy [31], whereas
another report showed increased IL-12 secretion by murine DCs
at 0.05 Gy, and this effect was reversed to the level of
nonirradiated DCs at 1 Gy [49]. The disparity between these
ﬁndings may be caused by differences in the behavior of human
and murine DCs; however, they may also reﬂect different
mechanisms of action for IR at extremely low doses (0.05–1 Gy)
compared with higher doses used for RT (2–6 Gy) [26, 50].
We found that the inhibitory effect of IR was restricted to IL-12
family members sharing the common p40 subunit. However, the
effect was considerably more pronounced for IL-23 than IL-
12p70. Interestingly, the maximal effect of IR was exerted at 6 Gy
with a plateau of effect at higher doses. This may be a result of
ATM reaching its maximum activation state at this dose. On the
other hand, the effect of IR did not extend to the other IL-12
family member, IL-27, comprising the IL-27p28 subunit and EBV-
induced gene 3, which are related to p35 and p40, respectively
[51]. Those ﬁndings demonstrate the highly selective effect of IR
on DC functions with a prevalence to inhibit Th17 responses.
The lack of effect of IR on TNF-a and IL-1b had important
consequences for our multicellular model, as it allowed activated
DCs to sustain their interactions with FBs and generate the PGE2
feedback loop [3]. Irradiated FBs also continued to support the
production of IL-23 by DCs, irrespective of the dose of IR to
which FBs were exposed. This was observed not only with an
FB cell line but also with primary dermal FBs, thus supporting the
potential physiologic importance of this observation.
FBs (resting, TLR activated, or irradiated) were not responsi-
ble for the secretion of any of the cytokines affected by IR.
Previous reports describe FB expression of the IL23p19 subunit
upon stimulation with IL-1b [52], but to the best of our
knowledge, there are no reports of IL-23 heterodimer secretion
[53]. It is important to recognize the difference between
biologically active IL-23 heterodimer secreted by APC and IL-
23p19 monomer, and in the current study, we measured
heterodimeric IL-23 secretion [53].
It is known that FBs can enter a senescent phase when exposed
to IR yet remain viable [18, 44, 54]. This represents 1 of the
important mechanisms of tumor development, as in this state,
senescent FBs alter their phenotype and promote tumor growth
and invasion and render adjacent tumor cells increasingly radio
resistant [44]. Therefore, we assessed the effect of IR on FBs in
functional assays. PGE2 stimulates IL-23 secretion in human and
Figure 4. Mechanisms of IL-23 recovery from
irradiated DCs by FBs. FB-dependent IL-23 secre-
tion from irradiated DCs is mediated by soluble
factors and was independent of cell-cell contact.
(A) Fold increase in IL-23 secretion by DCs
separated from FBs with Transwell (0.3 mm)
treated with IR (summary of 3 donors). (B)
Addition of PGE2 to irradiated DCs up-regulates
IL-23 secretion (summary of 5 donors). (C) Up-
regulation of IL-23 secretion from irradiated DCs
by FBs is COX2 dependent. FBs were treated with
indomethacin for 24 h before (and throughout)
coculture with irradiated DCs (data from 3
experiments). (D) FBs did not affect pATM in
irradiated DCs. Irradiated mDCs cultured with FBs
(blue lines) or without FB (orange lines) show
similar levels of pATM. In both of these settings,
IR increased ATM activation when compared with
nonirradiated mDCs (red lines), as demonstrated
by intracellular staining for ﬂow cytometry at 2 and 12 h after IR (6 Gy, representative donor of 3). (E) Stimulation of TLR4-activated DCs with the
cAMP agonist forskolin immediately following exposure to IR increased IL-23 secretion (data from 3 representative donors.) *0.05 . P $ 0.01,
**0.01 . P $ 0.001. Results are presented as means 6 SD.
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murine DCs [2, 41, 55, 56]. Previous reports have published
conﬂicting data regarding regulation of PGE2 secretion by
gingival FBs irradiated with a low-level diode laser [57, 58]. In our
model, irradiation of dermal FB did not alter PGE2 secretion in
response to exogenous TNF-a and IL-1b, and this likely accounts
for their continued capacity to augment IL-23 release by
nonirradiated DCs. Therefore, irradiated FBs were unimpaired
in their ability to secrete soluble immune modulators and
maintained their capacity to respond to environmental stimuli.
According to recent reports, PGE2 stimulates IL-23 secretion
from DCs through activation of the cAMP/PKA pathway [40, 41],
and we previously described that IR down-regulates IL-23
through pATM kinase [33]. Interestingly, cAMP signaling
inhibits radiation-induced pATM in lung cancer [42]. Addition
of forskolin increased IL-23 secretion by irradiated DCs to levels
commensurate with those from irradiated DC-FB cocultures,
suggesting a role for cAMP. However, in contrast to Cho and
colleagues [42], coculture of irradiated DCs with FBs did not
affect pATM levels, despite up-regulated IL-23. This disparity may
be a result of differences in timing of cAMP and ATM activation.
Cho and coworkers [42] activated cAMP before irradiation of
cells, thus preventing pATM by activated protein phosphatase 2A.
In our study, DCs were irradiated before activation and
subsequent stimulation from FBs. As ATM is phosphorylated in
DCs within 15 min of IR [33], signals from FBs are received by
DCs too late to inhibit ATM activation. Therefore, it is even more
notable that up-regulation of IL-23 secretion by FBs occurred
despite ATM activation.
The impact of FBs on the ability of irradiated DCs to promote
Th17 responses was examined. Previously, we [2, 33] and others
[56] established the role of IL-23 in the generation of Th17. In
agreement with this, IL-17 secretion from T cells conditioned with
supernatants from DC-FB cocultures was enhanced compared with
supernatants from DC monoculture. PGE2 was shown to promote
Th17 directly and in conjunction with IL-23 [59, 60]. In our
model, the concentration of PGE2 secreted by FBs was unaffected
by IR. On the other hand, changes in IL-17 reﬂected differences in
IL-23 levels, demonstrating the biologic importance of FB-
dependent IL-23 secretion in regulation of adaptive immunity.
In summary, we show that although IR inhibits IL-23 secretion
from DC monocultures, the inclusion of FBs provides a positive-
feedback loop that serves to maintain IL-23 secretion by DCs. We
propose that this translates to enhanced Th17 responses in a
post-RT environment (Fig. 5), and studies to investigate this are
underway. As IL-17 is a critical factor driving postradiation
ﬁbrosis [24], this work identiﬁes a potential mechanism for the
pathologic consequences of radiation and chemotherapy [25,
61]. Importantly, it highlights the need for multicellular models
of the immune microenvironment. Insight into the complex
interactions between the immune system and stroma is necessary
to our understanding of pathology and for development of novel
therapeutic interventions.
AUTHORSHIP
A.M. undertook or supervised all experimental work, interpreted
the data, and wrote the manuscript. Q.W., S.S., R.V.S., and H.A.F.
undertook speciﬁc components of experimental work. A.S.
generated and characterized primary dermal FBs and wrote the
manuscript. I.S., J.M.R., J.G., and M.J.G. undertook statistical
analysis and wrote the manuscript. M.J.G. provided advice on
radiation responses. P.M.P. conceived of the original project idea
and supervised the research. A.M.J. conceived of the original
project idea, supervised the research, and wrote the manuscript.
ACKNOWLEDGMENTS
This work was generously funded by grants from the U.K. Medical
Research Council [MRC; H.A.F. was funded by a Research
Councils UK (RCUK)MRCClinical ResearchTraining Fellowship,
G0900336], Engineering and Physical Sciences Research Council
(EPSRC; J.G. is in receipt of an EPSRC Discipline Hopping Award,
EP/N007115/1),Matt’s Trust for Cancer Research, andUniversity
of Nottingham (A.M. is in receipt of a Vice Chancellor’s Research
Excellence Scholarship). The authors are grateful to Dr. Bruno
Figure 5. Model of DC-FB crosstalk governing IL-23-dependent Th17
responses after irradiation. (A) TLR activation of DCs in monoculture
elicits secretion of IL-1b, -6, and -23, which prime Th17 responses.
(B) The addition of FB to DC provides an important feedback loop
that serves to enhance IL-23 secretion and thus, augments Th17
responses. (C) Irradiation of DC monocultures selectively inhibits
IL-23 secretion. (D) However, the presence of FBs ensures that
irradiated DCs continue to secrete sufﬁcient IL-23 to generate Th17
responses. Importantly, the irradiation of FBs does not hinder their
reinforcement of IL-23 responses.
Malecka et al. Dendritic cell-fibroblast crosstalk
www.jleukbio.org Volume 100, August 2016 Journal of Leukocyte Biology 387
 Vol.100,  No.2 , pp:381-389, August, 2016Journal of Leukocyte Biology. 128.243.2.153 to IP www.jleukbio.orgDownloaded from 
Gran (University of Nottingham) for his critical evaluation of the
research leading to this manuscript and Dr. Lloyd Hamilton for
provision of BJ6 FBs.
DISCLOSURES
The authors declare no conﬂict of interest.
REFERENCES
1. Saalbach, A., Klein, C., Sleeman, J., Sack, U., Kauer, F., Gebhardt, C.,
Averbeck, M., Anderegg, U., Simon, J. C. (2007) Dermal ﬁbroblasts
induce maturation of dendritic cells. J. Immunol. 178, 4966–4974.
2. Saalbach, A., Klein, C., Schirmer, C., Briest, W., Anderegg, U., Simon,
J. C. (2010) Dermal ﬁbroblasts promote the migration of dendritic cells.
J. Invest. Dermatol. 130, 444–454.
3. Schirmer, C., Klein, C., von Bergen, M., Simon, J. C., Saalbach, A. (2010)
Human ﬁbroblasts support the expansion of IL-17-producing T cells via
up-regulation of IL-23 production by dendritic cells. Blood 116,
1715–1725.
4. Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini,
M. R., Baroni, G., Lanciotti, M., Serni, S., Chiarugi, P. (2014) Cancer-
associated ﬁbroblasts and M2-polarized macrophages synergize during
prostate carcinoma progression. Oncogene 33, 2423–2431.
5. Chiarugi, P. (2013) Cancer-associated ﬁbroblasts and macrophages:
friendly conspirators for malignancy. OncoImmunology 2, e25563.
6. Yarnold, J., Brotons, M. C. (2010) Pathogenetic mechanisms in radiation
ﬁbrosis. Radiother. Oncol. 97, 149–161.
7. Komatsu, N., Okamoto, K., Sawa, S., Nakashima, T., Oh-hora, M.,
Kodama, T., Tanaka, S., Bluestone, J. A., Takayanagi, H. (2014)
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune
arthritis. Nat. Med. 20, 62–68.
8. De Monte, L., Reni, M., Tassi, E., Clavenna, D., Papa, I., Recalde, H.,
Braga, M., Di Carlo, V., Doglioni, C., Protti, M. P. (2011) Intratumor T
helper type 2 cell inﬁltrate correlates with cancer-associated ﬁbroblast
thymic stromal lymphopoietin production and reduced survival in
pancreatic cancer. J. Exp. Med. 208, 469–478.
9. Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-
Leon, S., Arﬁ, V., Biota, C., Dofﬁn, A. C., Durand, I., Olive, D., Perez, S.,
Pasqual, N., Faure, C., Ray-Coquard, I., Puisieux, A., Caux, C., Blay, J. Y.,
Me´ne´trier-Caux, C. (2009) Regulatory T cells recruited through CCL22/
CCR4 are selectively activated in lymphoid inﬁltrates surrounding
primary breast tumors and lead to an adverse clinical outcome. Cancer
Res. 69, 2000–2009.
10. Fialova´, A., Partlova´, S., Sojka, L., Hroma´dkova´, H., Brtnicky´, T.,
Fucˇı´kova´, J., Kocia´n, P., Rob, L., Bartu˚nˇkova´, J., Spı´sˇek, R. (2013)
Dynamics of T-cell inﬁltration during the course of ovarian cancer: the
gradual shift from a Th17 effector cell response to a predominant
inﬁltration by regulatory T-cells. Int. J. Cancer 132, 1070–1079.
11. Bhatt, A., Curbishley, S. M., Houghton, E. L., Weston, C. J., Blahova, M.,
Adams, D. H. (2010) The Stromal Compartment of Hepatocellular
Carcinoma Promotes the Local Differentiation of Tolerogenic Dendritic
Cells. Gut 9, 30–31.
12. Kitamura, H., Cambier, S., Somanath, S., Barker, T., Minagawa, S.,
Markovics, J., Goodsell, A., Publicover, J., Reichardt, L., Jablons, D.,
Wolters, P., Hill, A., Marks, J. D., Lou, J., Pittet, J. F., Gauldie, J., Baron,
J. L., Nishimura, S. L. (2011) Mouse and human lung ﬁbroblasts regulate
dendritic cell trafﬁcking, airway inﬂammation, and ﬁbrosis through
integrin avb8-mediated activation of TGF-b. J. Clin. Invest. 121,
2863–2875.
13. Huber, L. C., Distler, O., Tarner, I., Gay, R. E., Gay, S., Pap, T. (2006)
Synovial ﬁbroblasts: key players in rheumatoid arthritis. Rheumatology
(Oxford) 45, 669–675.
14. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B.,
Sedgwick, J. D., McClanahan, T., Kastelein, R. A., Cua, D. J. (2005) IL-23
drives a pathogenic T cell population that induces autoimmune
inﬂammation. J. Exp. Med. 201, 233–240.
15. Tang, C., Chen, S., Qian, H., Huang, W. (2012) Interleukin-23: as a drug
target for autoimmune inﬂammatory diseases. Immunology 135, 112–124.
16. Yannam, G. R., Gutti, T., Poluektova, L. Y. (2012) IL-23 in infections,
inﬂammation, autoimmunity and cancer: possible role in HIV-1 and
AIDS. J. Neuroimmune Pharmacol. 7, 95–112.
17. Liu, F. L., Chen, C. H., Chu, S. J., Chen, J. H., Lai, J. H., Sytwu, H. K.,
Chang, D. M. (2007) Interleukin (IL)-23 p19 expression induced by IL-
1beta in human ﬁbroblast-like synoviocytes with rheumatoid arthritis via
active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology
(Oxford) 46, 1266–1273.
18. Suzuki, H., Ogawa, H., Miura, K., Haneda, S., Watanabe, K., Ohnuma, S.,
Sasaki, H., Sase, T., Kimura, S., Kajiwara, T., Komura, T., Toshima, M.,
Matsuda, Y., Shibata, C., Sasaki, I. (2012) IL-23 directly enhances the
proliferative and invasive activities of colorectal carcinoma. Oncol. Lett. 4,
199–204.
19. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K.,
Basham, B., McClanahan, T., Kastelein, R. A., Oft, M. (2006) IL-23
promotes tumour incidence and growth. Nature 442, 461–465.
20. Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., Yu, H. (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling
pathway. J. Exp. Med. 206, 1457–1464.
21. He, D., Li, H., Yusuf, N., Elmets, C. A., Li, J., Mountz, J. D., Xu, H. (2010)
IL-17 promotes tumor development through the induction of tumor
promoting microenvironments at tumor sites and myeloid-derived
suppressor cells. J. Immunol. 184, 2281–2288.
22. Alexandrakis, M. G., Pappa, C. A., Miyakis, S., Sﬁridaki, A., Kafousi, M.,
Alegakis, A., Stathopoulos, E. N. (2006) Serum interleukin-17 and its
relationship to angiogenic factors in multiple myeloma. Eur. J. Intern.
Med. 17, 412–416.
23. Zhu, X., Mulcahy, L. A., Mohammed, R. A., Lee, A. H., Franks, H. A.,
Kilpatrick, L., Yilmazer, A., Paish, E. C., Ellis, I. O., Patel, P. M., Jackson,
A. M. (2008) IL-17 expression by breast-cancer-associated macrophages:
IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res.
10, R95.
24. Wang, B. Z., Wang, L. P., Han, H., Cao, F. L., Li, G. Y., Xu, J. L., Wang,
X. W., Wang, L. X. (2014) Interleukin-17A antagonist attenuates
radiation-induced lung injuries in mice. Exp. Lung Res. 40, 77–85.
25. Gasse, P., Riteau, N., Vacher, R., Michel, M. L., Fautrel, A., di Padova, F.,
Fick, L., Charron, S., Lagente, V., Eberl, G., Le Bert, M., Quesniaux, V. F.,
Huaux, F., Leite-de-Moraes, M., Ryffel, B., Couillin, I. (2011) IL-1 and IL-
23 mediate early IL-17A production in pulmonary inﬂammation leading
to late ﬁbrosis. PLoS One 6, e23185.
26. Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C.,
Andersen, E., Bentzen, J., Bastholt, L., Hansen, O., Johansen, J.,
Andersen, L., Evensen, J. F. (2003) Five compared with six fractions per
week of conventional radiotherapy of squamous-cell carcinoma of head
and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362,
933–940.
27. Pierce, S. M., Recht, A., Lingos, T. I., Abner, A., Vicini, F., Silver, B.,
Herzog, A., Harris, J. R. (1992) Long-term radiation complications
following conservative surgery (CS) and radiation therapy (RT) in
patients with early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 23,
915–923.
28. Gaspar, L. E., Mehta, M. P., Patchell, R. A., Burri, S. H., Robinson, P. D.,
Morris, R. E., Ammirati, M., Andrews, D. W., Asher, A. L., Cobbs, C. S.,
Kondziolka, D., Linskey, M. E., Loefﬂer, J. S., McDermott, M., Mikkelsen,
T., Olson, J. J., Paleologos, N. A., Ryken, T. C., Kalkanis, S. N. (2010) The
role of whole brain radiation therapy in the management of newly
diagnosed brain metastases: a systematic review and evidence-based
clinical practice guideline. J. Neurooncol. 96, 17–32.
29. Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y.,
Beckett, M., Sharma, R., Chin, R., Tu, T., Weichselbaum, R. R., Fu,
Y. X. (2009) Therapeutic effects of ablative radiation on local tumor
require CD8+ T cells: changing strategies for cancer treatment. Blood
114, 589–595.
30. Teitz-Tennenbaum, S., Li, Q., Davis, M., Chang, A. E. (2004) Mechanisms
involved in radiation enhancement of intratumoral dendritic cell
therapy. Ann. Surg. Oncol. 11, S69.
31. Merrick, A., Errington, F., Milward, K., O’Donnell, D., Harrington, K.,
Bateman, A., Pandha, H., Vile, R., Morrison, E., Selby, P., Melcher, A.
(2005) Immunosuppressive effects of radiation on human dendritic cells:
reduced IL-12 production on activation and impairment of naive T-cell
priming. Br. J. Cancer 92, 1450–1458.
32. Bauer, M., Goldstein, M., Christmann, M., Becker, H., Heylmann, D.,
Kaina, B. (2011) Human monocytes are severely impaired in base and
DNA double-strand break repair that renders them vulnerable to
oxidative stress. Proc. Natl. Acad. Sci. USA 108, 21105–21110.
33. Wang, Q., Franks, H. A., Lax, S. J., El Refaee, M., Malecka, A., Shah, S.,
Spendlove, I., Gough, M. J., Seedhouse, C., Madhusudan, S., Patel, P. M.,
Jackson, A. M. (2013) The ataxia telangiectasia mutated kinase pathway
regulates IL-23 expression by human dendritic cells. J. Immunol. 190,
3246–3255.
34. Franks, H. A., Wang, Q., Lax, S. J., Collins, M. K., Escors, D., Patel, P. M.,
Jackson, A. M. (2014) Novel function for the p38-MK2 signaling pathway
in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy
donors and advanced cancer patients; inhibition of p38 enhances IL-12
whilst suppressing IL-10. Int. J. Cancer 134, 575–586.
35. Jackson, A. M., Mulcahy, L. A., Porte, J., Franks, H. A., El Refaee, M.,
Wang, Q., Shah, S., Zhu, X., Patel, P. M. (2010) Role of mitogen-activated
protein kinase and PI3K pathways in the regulation of IL-12-family
cytokines in dendritic cells and the generation of T H-responses. Eur.
Cytokine Netw. 21, 319–328.
36. Wang, Q., Franks, H. A., Porte, J., El Refaee, M., Shah, S., Crooks, J.,
Patel, P. M., Jackson, A. M. (2011) Novel approach for interleukin-23 up-
regulation in human dendritic cells and the impact on T helper type 17
generation. Immunology 134, 60–72.
388 Journal of Leukocyte Biology Volume 100, August 2016 www.jleukbio.org
 Vol.100,  No.2 , pp:381-389, August, 2016Journal of Leukocyte Biology. 128.243.2.153 to IP www.jleukbio.orgDownloaded from 
37. Bukata, S. V., Gelinas, J., Wei, X., Rosier, R. N., Puzas, J. E., Zhang, X.,
Schwarz, E. M., Song, X. Y., Griswold, D. E., O’Keefe, R. J. (2004) PGE2
and IL-6 production by ﬁbroblasts in response to titanium wear debris
particles is mediated through a Cox-2 dependent pathway. J. Orthop. Res.
22, 6–12.
38. Bauer, M., Goldstein, M., Heylmann, D., Kaina, B. (2012) Human
monocytes undergo excessive apoptosis following temozolomide
activating the ATM/ATR pathway while dendritic cells and macrophages
are resistant. PLoS One 7, e39956.
39. Itano, A. A., Jenkins, M. K. (2003) Antigen presentation to naive CD4
T cells in the lymph node. Nat. Immunol. 4, 733–739.
40. Kocieda, V. P., Adhikary, S., Emig, F., Yen, J. H., Toscano, M. G., Ganea,
D. (2012) Prostaglandin E2-induced IL-23p19 subunit is regulated by
cAMP-responsive element-binding protein and C/AATT enhancer-
binding protein b in bone marrow-derived dendritic cells. J. Biol. Chem.
287, 36922–36935.
41. Shi, Q., Yin, Z., Zhao, B., Sun, F., Yu, H., Yin, X., Zhang, L., Wang, S.
(2015) PGE2 elevates IL-23 production in human dendritic cells via a
cAMP dependent pathway. Mediators Inﬂamm. 2015, 984690.
42. Cho, E. A., Kim, E. J., Kwak, S. J., Juhnn, Y. S. (2014) cAMP signaling
inhibits radiation-induced ATM phosphorylation leading to the
augmentation of apoptosis in human lung cancer cells. Mol. Cancer 13, 36.
43. Sugita, K., Kabashima, K., Atarashi, K., Shimauchi, T., Kobayashi, M.,
Tokura, Y. (2007) Innate immunity mediated by epidermal keratinocytes
promotes acquired immunity involving Langerhans cells and T cells in
the skin. Clin. Exp. Immunol. 147, 176–183.
44. Papadopoulou, A., Kletsas, D. (2011) Human lung ﬁbroblasts prematurely
senescent after exposure to ionizing radiation enhance the growth of
malignant lung epithelial cells in vitro and in vivo. Int. J. Oncol. 39, 989–999.
45. Shiao, S. L., Coussens, L. M. (2010) The tumor-immune
microenvironment and response to radiation therapy. J. Mammary Gland
Biol. Neoplasia 15, 411–421.
46. Barcellos-Hoff, M. H., Park, C., Wright, E. G. (2005) Radiation and the
microenvironment—tumorigenesis and therapy. Nat. Rev. Cancer 5,
867–875.
47. Teitz-Tennenbaum, S., Li, Q., Okuyama, R., Davis, M. A., Sun, R.,
Whitﬁeld, J., Knibbs, R. N., Stoolman, L. M., Chang, A. E. (2008)
Mechanisms involved in radiation enhancement of intratumoral
dendritic cell therapy. J. Immunother. 31, 345–358.
48. Crittenden, M. R., Savage, T., Cottam, B., Baird, J., Rodriguez, P. C.,
Newell, P., Young, K., Jackson, A. M., Gough, M. J. (2014) Expression of
arginase I in myeloid cells limits control of residual disease after radiation
therapy of tumors in mice. Radiat. Res. 182, 182–190.
49. Shigematsu, A., Adachi, Y., Koike-Kiriyama, N., Suzuki, Y., Iwasaki, M.,
Koike, Y., Nakano, K., Mukaide, H., Imamura, M., Ikehara, S. (2007)
Effects of low-dose irradiation on enhancement of immunity by dendritic
cells. J. Radiat. Res. (Tokyo) 48, 51–55.
50. Mestas, J., Hughes, C. C. (2004) Of mice and not men: differences
between mouse and human immunology. J. Immunol. 172, 2731–2738.
51. Rousseau, F., Basset, L., Froger, J., Dinguirard, N., Chevalier, S.,
Gascan, H. (2010) IL-27 structural analysis demonstrates similarities
with ciliary neurotrophic factor (CNTF) and leads to the
identiﬁcation of antagonistic variants. Proc. Natl. Acad. Sci. USA 107,
19420–19425.
52. Zhu, L., Wu, Y., Wei, H., Yang, S., Zhan, N., Xing, X., Peng, B. (2012) Up-
regulation of IL-23 p19 expression in human periodontal ligament
ﬁbroblasts by IL-1b via concurrent activation of the NF-kB and MAPKs/
AP-1 pathways. Cytokine 60, 171–178.
53. Brentano, F., Ospelt, C., Stanczyk, J., Gay, R. E., Gay, S., Kyburz, D.
(2009) Abundant expression of the interleukin (IL)23 subunit p19, but
low levels of bioactive IL23 in the rheumatoid synovium: differential
expression and Toll-like receptor-(TLR) dependent regulation of the
IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann. Rheum. Dis.
68, 143–150.
54. Di Leonardo, A., Linke, S. P., Clarkin, K., Wahl, G. M. (1994) DNA
damage triggers a prolonged p53-dependent G1 arrest and long-term
induction of Cip1 in normal human ﬁbroblasts. Genes Dev. 8, 2540–2551.
55. Sheibanie, A. F., Tadmori, I., Jing, H., Vassiliou, E., Ganea, D. (2004)
Prostaglandin E2 induces IL-23 production in bone marrow-derived
dendritic cells. FASEB J. 18, 1318–1320.
56. Qian, X., Gu, L., Ning, H., Zhang, Y., Hsueh, E. C., Fu, M., Hu, X., Wei,
L., Hoft, D. F., Liu, J. (2013) Increased Th17 cells in the tumor
microenvironment is mediated by IL-23 via tumor-secreted prostaglandin
E2. J. Immunol. 190, 5894–5902.
57. Pourzarandian, A., Watanabe, H., Ruwanpura, S. M., Aoki, A., Noguchi,
K., Ishikawa, I. (2005) Er:YAG laser irradiation increases prostaglandin E
production via the induction of cyclooxygenase-2 mRNA in human
gingival ﬁbroblasts. J. Periodontal Res. 40, 182–186.
58. Sakurai, Y., Yamaguchi, M., Abiko, Y. (2000) Inhibitory effect of low-level
laser irradiation on LPS-stimulated prostaglandin E2 production and
cyclooxygenase-2 in human gingival ﬁbroblasts. Eur. J. Oral Sci. 108,
29–34.
59. Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-
Lombard, P., Ferrari-Lacraz, S., Dayer, J. M. (2008) Prostaglandin E2
synergistically with interleukin-23 favors human Th17 expansion. Blood
112, 3696–3703.
60. Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto,
Y., Narumiya, S. (2009) Prostaglandin E2-EP4 signaling promotes
immune inﬂammation through Th1 cell differentiation and Th17 cell
expansion. Nat. Med. 15, 633–640.
61. Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas,
I. O., Cheever, A. W., Wynn, T. A. (2010) Bleomycin and IL-1beta-
mediated pulmonary ﬁbrosis is IL-17A dependent. J. Exp. Med. 207,
535–552.
KEY WORDS:
cytokine • immunity • cancer
Malecka et al. Dendritic cell-fibroblast crosstalk
www.jleukbio.org Volume 100, August 2016 Journal of Leukocyte Biology 389
 Vol.100,  No.2 , pp:381-389, August, 2016Journal of Leukocyte Biology. 128.243.2.153 to IP www.jleukbio.orgDownloaded from 
 10.1189/jlb.3A1015-474RAccess the most recent version at doi:
2016 100: 381-389 originally published online April 5, 2016J Leukoc Biol 
  
Anna Malecka, Qunwei Wang, Sabaria Shah, et al. 
  
responses after exposure to ionizing radiation
Stromal fibroblasts support dendritic cells to maintain IL-23/Th17
  
References
  
 http://www.jleukbio.org/content/100/2/381.full.html#ref-list-1
This article cites 61 articles, 22 of which can be accessed free at:
Subscriptions
  
http://www.jleukbio.org/site/misc/Librarians_Resource.xhtml
 is online at Journal of Leukocyte BiologyInformation about subscribing to 
Permissions
  
http://www.jleukbio.org/site/misc/Librarians_Resource.xhtml
Submit copyright permission requests at:
Email Alerts
  
http://www.jleukbio.org/cgi/alerts
Receive free email alerts when new an article cites this article - sign up at
© The Author(s)
 Vol.100,  No.2 , pp:381-389, August, 2016Journal of Leukocyte Biology. 128.243.2.153 to IP www.jleukbio.orgDownloaded from 
